The research identifies a dysfunctional EIF3H/YAP proteolytic axis as a key mediator between cancer-associated adipocytes and drug response
T., Atisso, C
There is no contraindication multi-select, no MTC or MEN-2 screen, no pancreatitis screen, no pregnancy screen, no eating disorder screen, no mental-health screen, no substance-use screen, no medical-history multi-select, no allergy capture, no current medications list, no blood pressure, no heart rate, no comorbidity capture, and no family history screen captured in the flow
For example, Bessesen says your doctor may recommend continuing with treatment if you have high blood pressure or diabetes that have improved while taking a GLP-1
weekly, cheaper vs
GLP-1 weight loss medication may help reduce appetite, but long-term success still requires nutrition, hydration, protein, habit change, monitoring, mindset support, and daily reinforcement